MedTrace Logo

Dengue Serostatus Study in the Philippines

NCT03465254 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 2996

Last updated 2023-05-17

No results posted yet for this study

Summary

This is an observational study for 5 years, and aims to determine the risk of developing dengue among Philippine children who are eligible to receive the dengue vaccine during the DOH mass dengue vaccination, by dengue serostatus at baseline.

Conditions

  • Dengue
  • Severe Dengue
  • Dengue Fever
  • Virologically-confirmed Dengue

Sponsors & Collaborators

  • Department of Health, Philippines

    collaborator OTHER_GOV

  • World Health Organization

    collaborator OTHER

  • Research Institute for Tropical Medicine, Philippines

    collaborator OTHER_GOV

  • University of North Carolina

    collaborator OTHER

  • La Jolla Institute for Allergy & Immunology

    collaborator OTHER

  • International Vaccine Institute

    collaborator OTHER

  • University of the Philippines

    lead OTHER

Principal Investigators

  • Jacqueline L. Deen, MD · UPM-NIH, Institute of Child Health and Human Development

Eligibility

Min Age
9 Years
Max Age
14 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-11-30
Primary Completion
2022-10-31
Completion
2023-06-30

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03465254 on ClinicalTrials.gov